Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Ch. Niranjan Patro"'
Autor:
Hrushikesh Raut, Chetana Jadhav, Karishma Shetty, Neha Laxane, Harsh P. Nijhawan, GSN Koteswara Rao, Rajasekhar Reddy Alavala, Garima Joshi, Ch. Niranjan Patro, Govind Soni, Khushwant S. Yadav
Publikováno v:
OpenNano, Vol 8, Iss , Pp 100103- (2022)
The USFDA has approved sorafenib tosylate for the treatment of thyroid cancer, kidney cancer, and hepatocellular carcinoma. Conventional formulations of sorafenib tosylate have challenges of solubility, permeability, side effects, and drug resistance
Externí odkaz:
https://doaj.org/article/bd27e1049f554914bcd61dc18c58b097
Autor:
Muddana Eswara Bhanoji Rao, Sarwar Beg, Subas Chandra Dinda, Suryakanta Swain, Jammula Sruti, Upali A Behera, Ch. Niranjan Patro
Publikováno v:
Drug Development and Industrial Pharmacy. 39:548-560
The objectives of present work was to design and characterize the rabeprazole sodium loaded microcapsules prepared by solvent evaporation technique using ethyl cellulose (EC) based various mucoadhesive polymer, followed by a triple coating with Eudra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc5899e5310cb2df1968299d8939d97c
https://doi.org/10.3109/03639045.2012.676047
https://doi.org/10.3109/03639045.2012.676047
Publikováno v:
Current drug delivery. 8(4)
Transdermal route has been recognized as a promising drug delivery system for systemic delivery of drugs and provides the advantage of avoidance of first-pass effect, ease of use, better patient compliance, maintaining constant blood level for longer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d6d967833eeac37ec6d682e45967ade3
https://pubmed.ncbi.nlm.nih.gov/21453254
https://pubmed.ncbi.nlm.nih.gov/21453254